Contributors


Ilana Cass, M.D.

Latest:

Ilana Cass on Potential Consequences of Preventive Surgery

Ilana Cass, M.D. of Cedars-Sinai Medical Center discusses some of the unknown potential side effects of preventive surgery for ovarian cancer.



ALEX SPIRA, M.D., PH.D., FACP

Latest:

Progress in Sarcoma Treatment, But Still a Long Journey Ahead

New clinical trials have oncologists excited about potential new therapies for patients.


Dr. Guillermo Garcia-Manero

Latest:

Investigational Drug Combination Could Address Unmet Need in TP53-Positive MDS

The phase 3 trial evaluating eprenetapopt plus Vidaza completed enrollment recently, and could lead to a new standard of care with positive results, according to Dr. Guillermo Garcia-Manero.


Amin A. Ramzan, M.D.

Latest:

Opioids Must Be Used Responsibly Amid a National Epidemic

Many patients suffer from chronic pain, making opioids essential for care.


Michael A. Postow

Latest:

Seeing Red

Rash is the most common side effect of cancer immunotherapies, but patients should watch for more serious issues.


Debra Jarvis

Latest:

Prince & the Gun Oil

Sex toys and lubricant and erotic books, oh my!


VERONICA BROWN-MOSELEY, ESQUIRE

Latest:

Financial Healing From Cancer

For some with overwhelming medical expenses, bankruptcy can offer a solution.


Bobbie Chew Bigby

Latest:

The Heart, Soul and Laughter of Healing

An Extraordinary Healer essay honoring MICHELLE GUTIERREZ, RN, OCN [OKLAHOMA CANCER SPECIALISTS AND RESEARCH INSTITUTE, TULSA, OKLAHOMA]


Emily Ward

Latest:

Fighting the Uncertainty of Cancer With Self-Education

A seven-year mesothelioma survivor encourages patients with cancer to be their own advocate.



Nancy Reuben Greenfield

Latest:

Back in Action After DCIS

Treatment options for ductal carcinoma in situ (DCIS), a precursor to breast cancer.


Simone Gampel, RD, CDE

Latest:

Lifestyle Tips for Managing Lymphedema

Lymphedema is a common side effect that may affect a cancer survivor months or even years after treatments such as surgery or radiation therapy. Here are some tips to help manage lymphedema.


Marci Dahl Office Manager, HMS Oncology

Latest:

Moving Mountains to Help Patients - and Staff

An Extraordinary Healer essay honoring IVY BREWSTER, RN, OCN [CHARGE NURSE, ST. JOSEPH HEALTH, HUMBOLDT PEALS FAMILY CHEMOTHERAPY OUTPATIENT CENTER, EUREKA, CALIFORNIA]



Frederic C. Kass

Latest:

Frederic C. Kass on Dealing With Fear Associated With a Cancer Diagnosis

Frederic C. Kass, from the Cancer Center of Santa Barbara, discusses the importance of a multidisciplinary team in dealing with a patient's fear.




Nicholas Esposito

Latest:

The Melanoma Effect

If I ever got sick or injured I would go to the children’s hospital, but that was nothing like a real hospital where people are fighting for their life day-in and day-out. I absolutely hated it, and still do. I was in Emory Hospital visiting my dad two to three times a week for about six months, and every time I walked in that place, it just gave me the heebie-jeebies.


Beth Meagher

Latest:

The Importance of Early Detection in Cancer Care

Beth Meagher, of Deloitte Consulting, discusses the importance of early cancer detection.


Peter Borchmann, M.D.

Latest:

CAR T-Cell Therapy Offers Hope in DLBCL

CAR-T cell therapy is generating excitement for the treatment of diffuse large B-cell lymphoma, according to an update from the JULIET trial.


Eric Kingson

Latest:

What I've Learned About Living Well with Illness

Cancer—the uninvited teacher— leaves a new understanding of what’s important.



Maureen Boesen

Latest:

Making Lemonade: When Life Hands You a BRCA Misdiagnosis

Living with the challenges of having a BRCA1 gene mutation, a woman faces a different struggle when she discovers that diagnosis was wrong.


Trine Alma Knudsen, M.D.

Latest:

Comparing Two MPN Drugs

An expert discusses a trial comparing recombinant interferon alpha-2 with hydroxyurea in patients with myeloproliferative neoplasms (MPNs).


Kristi Rosa

Latest:

KITE-363 Shows High Response in B-Cell Lymphoma With Manageable Safety

The dual-targeting CAR T-cell therapy KITE-363 showed positive response rates and manageable side effects in relapsed or refractory B-cell lymphoma.



Lynne Anderson

Latest:

Cancer Chameleon

While sometimes one of the most aggressive of childhood cancers, neuroblastoma frequently goes away on its own.


Amy K. Erickson

Latest:

Powers of Prediction

Predictive markers help oncologists match patients with the most effective treatments.


KAREN J. RIBLER

Latest:

Trials and Tribulations: Navigating the Clinical Trial Space

Finding her way into a clinical trial took a lot of research for one patient with ovarian cancer. Now, she’s guiding others.